Get started
Author

Hugo Daniel Sanabria

Observed names: H D Sanabria, H Sanabria, H. D. Sanabria, H.D. Sanabria, Hugo D. Sanabria, Hugo Sanabria
ORCID: 0000-0002-5600-2617
Observed ORCID: 0000-0002-5600-2617
OpenAlex ID: A5004412277
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
2022 · Peter Rossing, Stefan D. Anker, et al. · Diabetes Care · 242
PDF
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis
2023 · Rajiv Agarwal, Wanzhu Tu, et al. · Annals of Internal Medicine · 125
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
2022 · Peter Rossing, Ellen Burgess, et al. · Diabetes Care · 41
PDF
Medium-term glycemic control in diabetics before coronary bypass surgery.
2015 · José M Santos, Roberto R Favaloro, et al. · PubMed · 11
Incretins and selective renal sodium-glucose co-transporter 2 inhibitors in hypertension and coronary heart disease
2015 · Ramiro A Sanchez, Hugo Sanabria, et al. · World Journal of Diabetes · 10
PDF
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial
2025 · Stephen J. Nicholls, Donna H. Ryan, et al. · JAMA Cardiology · 8
Relación entre enfermedad cardiovascular y renal en una muestra de pacientes con diabetes del mundo real
2021 · Emiliano Salmeri, Alicia Elbert, et al. · Archivos de cardiología de México · 3
PDF
Efectos del aislamiento social, preventivo y obligatorio en pacientes con diabetes tipo 2
2020 · Ezequiel H. Forte, Carolina Gómez-Martín, et al. · Archivos de cardiología de México · 3
PDF
Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial
2026 · John W. Ostrominski, Jorge Plutzky, et al. · JAMA Cardiology · 2
Características clínicas y control cardiometabólico de personas con diabetes en el consultorio de cardiología en la República Argentina
2020 · Ezequiel Hernan Forte, Carlos Javier Buso, et al. · Revista Argentina de Cardiología · 2
Guía para el tratamiento de la diabetes mellitus tipo 2 en el adulto
2025 · Víctor Commendatore, Alejandro De Dios, et al. · Revista de la Sociedad Argentina de Diabetes · 1
PDF
Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897
2023 · Peter Rossing, Ellen Burgess, et al. · Diabetes Care · 1
PDF
[Cardiovascular effects of new non-insulinic anti-diabetes drugs].
2018 · Guillermo Dieuzeide, Félix Puchulu, et al. · PubMed · 1
Sex Based Differences in Achievement of Ldl Goals After an Acs: Subanalysis of a Prospective Treatment Algorithm Based on Admission Ldl and Baseline Therapy.
2026 · Alan Sigal, Juan Pablo Yapur, et al. · Atherosclerosis
Optimization of Lipid Management Post Acute Coronary Syndrome: a Patient-centric Algorithm Based on Admission Ldl Levels and Baseline Pharmacotherapy
2026 · Alan Sigal, Juan Pablo Yapur, et al. · Atherosclerosis
Coronary calcium score in primary prevention: clinical characteristics and segmental distribution from an Argentine clinic registry
2025 · J M Rodriguez Platas, P Kuschnir, et al. · European Heart Journal
Assessment of medical behaviour following a non-zero coronary artery calcium score at a monovalent centre in Argentina
2025 · M R Rodriguez, P Kuschnir, et al. · European Heart Journal
Epicardial Adipose Tissue and Its Association with Cardiac MorphologicalAbnormalities and Markers of Diastolic Dysfunction
2025 · Ezequiel Forte, Pedro Antonio Becerra, et al. · Revista Argentina de Cardiología
Grasa epicárdica y su relación con alteraciones morfológicas cardiacas y marcadores de disfunción diastólica
2025 · Ezequiel Forte, Pedro Antonio Becerra, et al. · Revista Argentina de Cardiología
PDF
Resolution of ventricular dysfunction and fibrosis in a young woman with primary hyperaldosteronism
2025 · M.d.R. Rodriguez, F.N. Ballari, et al. · Hipertensión y Riesgo Vascular
Insuficiencia cardíaca en diabetes: ¿estamos llegando tarde?
2025 · Hugo Sanabria · Revista de la Sociedad Argentina de Diabetes
PDF
Metformina: ¿Debería ser la primera opción terapéutica en el paciente con diabetes de alto riesgo?
2025 · Hugo Daniel Sanabria, Augusto Lavalle Cobo · Revista Argentina de Cardiología
PDF
Capítulo 6: Inhibidores Del Cotransporte Sglt-2
2024 · Felipe Inserra, Hugo Sanabria, et al. · Revista de la Sociedad Argentina de Diabetes
PDF
Impacto de los tratamientos para el control glucémico en la insuficiencia cardíaca
2022 · Hugo Sanabria · Revista de la Sociedad Argentina de Diabetes
PDF
Honrar el juramento hipocrático
2022 · Hugo Daniel Sanabria, Jimena Soutelo · Revista de la Sociedad Argentina de Diabetes
PDF
Works count: 37
Citation count: 450
H-index: 6
I10-index: 5
Year
Topic
Type